Ligand validation:8PT9

DVI: methyl (1S,3S)-1-methyl-3-[[3-[[3-methyl-4-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]carbamoyl]phenyl]carbamoyl]-4-oxidanylidene-cyclohexane-1-carboxylate

DVI is a Ligand Of Interest in 8PT9 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8PT9_DVI_A_401	47%	12%	0.171	0.911	1.82	2.21	8	17	0	0	100%	1
8PT9_DVI_B_401	33%	13%	0.215	0.894	1.82	2.18	8	20	0	0	100%	1
8PT9_DVI_C_401	29%	22%	0.255	0.913	1.27	1.97	3	13	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.